Yi Fei Zhu
Corporate Officer/Principal presso I-MAB
Profilo
Yi Fei Zhu is currently the Chief Commercial Officer at I-Mab.
Prior to this, he held the position of Vice President & General Manager-Sales Division at Qilu Pharmaceutical Co., Ltd.
and Chief Commercial Officer at BeiGene Ltd.
He also previously worked as Chief Commercial Officer at I-MAB Biopharma Co., Ltd.
Zhu received his undergraduate degree from Zhejiang University in 1992.
Posizioni attive di Yi Fei Zhu
| Società | Posizione | Inizio |
|---|---|---|
| I-MAB | Corporate Officer/Principal | 10/08/2020 |
Precedenti posizioni note di Yi Fei Zhu
| Società | Posizione | Fine |
|---|---|---|
| BEIGENE, LTD. | Corporate Officer/Principal | 01/03/2019 |
Qilu Pharmaceutical Co., Ltd.
 Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Sales & Marketing | 01/03/2019 |
I-MAB Biopharma Co., Ltd.
 I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Sales & Marketing | - |
Formazione di Yi Fei Zhu
| Zhejiang University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BEIGENE, LTD. | Health Technology |
| I-MAB | Health Technology |
| Aziende private | 2 |
|---|---|
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
Qilu Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology Qilu Pharmaceutical Co., Ltd. manufactures and markets generic drugs. It offers services in the areas of oncology, infections, cerebrovascular and cardiovascular, psychological and neurological system, respiratory system and ophthalmological diseases. The company was founded in 1958 and is headquartered in Jinan, China. | Health Technology |
- Borsa valori
- Insiders
- Yi Fei Zhu
